Medicinal Product Shortages - update - 31 May 2023

Notice type: Advisory

Date: 31/05/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Caverject 20mcg Powder and Solvent for Solution for Injection

PA0822/115/003

Pfizer Healthcare Ireland

Alprostadil

Chloromycetin 0.5% w/v Redidrops Eye Drops

PA1142/021/001

Amdipharm Limited

Chloramphenicol

Fucidin Cream

PA0046/004/012

Leo Laboratories Limited

Fusidic acid

Ikervis 1 mg/ml Eye Drops

EU/1/15/990/001

Santen OY

Ciclosporin

Thamicarb 84mg/ml Oral Solution

PA22697/017/001

Syri Pharma Limited t/a Thame Laboratories

Sodium hydrogen carbonate

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Adenocor 3 mg/ml Solution for Injection

PA0540/139/001

Sanofi-Aventis Ireland Limited T/A SANOFI

Adenosine

Adenosine 3mg/ml Solution for Injection in Pre Filled Syringe

PA2059/004/001

Fresenius Kabi Deutschland GmbH

Adenosine

Atorvastatin Teva 10mg Film Coated Tablets

PA0749/110/001

Teva Pharma B.V.

Atorvastatin

Azyter 15 mg/g Eye Drops Solution

PA1107/004/001

Laboratoires Thea

Azithromycin

Azzalure 125 Speywood Units, Powder for Solution for Injection

PA1613/001/001

Ipsen Pharma

Clostridium Botulinum Toxin Type A

Dobutamine 12.5mg/ml Concentrate for Solution for Infusion

PA0073/137/001

Mercury Pharmaceuticals (Ireland) Ltd

Dobutamine

Isomel 60mg Prolonged Release Tablet

PA2261/002/001

Dexcel Pharma GmbH

Isosorbid-5-mononitrat

Kamiren 4mg Prolonged-Release Tablets

PA1347/038/001

KRKA, d.d., Novo mesto

Doxazosin

Ketalar 50 mg/ml Solution for Injection/Infusion

PA0822/013/002

Pfizer Healthcare Ireland

Ketamine

Lactulose Fresenius 670mg/ml Oral Solution

PA0773/003/001

Fresenius Kabi Austria GmbH

Lactulose

Lansoprazole Teva Pharma 30mg Gastro-Resistant Hard Capsules

PA1986/008/002

Teva B.V.

Lansoprazole

Lycimor 300mg Hard Capsules

PA1986/118/001

Teva B.V.

Lymecycline

Raporsin 4mg Prolonged Release Tablets

PA2315/005/001

Accord Healthcare Ireland Ltd.

Doxazosin

Senokot 7.5 mg/5 ml Syrup

PA0979/016/003

Reckitt Benckiser Ireland Ltd

Sennoside b

Solpadeine Capsules

24 pack

PA1186/011/002

Chefaro Ireland DAC

Paracetamol, codeine & caffeine

Sotoger 80mg Tablets

PA0577/021/001

McDermott Laboratories Ltd., T/A Gerard Laboratories

Sotalol

Tarceva 100mg Film Coated Tablets

EU/1/05/311/002

Roche Registration GmbH

Erlotinib

Tyvense 30mg Capsules

PA0540/139/001

Takeda Pharmaceuticals International AG Ireland Branch

Lisdexamfetamine

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back